Report results from the UNI-494 Phase 1 dose-ranging study
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 14 Aug 2024
- Due
- 31 Dec 2024
- Delivered
- 9 Oct 2024
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“expect to report results in the third quarter of this year”
What we found
Evidence strength B What the grades mean
Unicycive reported UNI-494 Phase 1 dose-ranging study results on October 9, 2024, within Q3 2024 deadline, showing successful completion and detailed tolerability findings.
-
B Unicycive Announces Second Quarter 2024 Financial Results and Provides Business Update
“We have completed enrollment in the UNI-494 Phase 1 dose-ranging study and expect to report results in the third quarter of this year.” ✓ confirmed on the page
-
B Unicycive Therapeutics Successfully Completes UNI-494 Phase 1 Study in Healthy Volunteers
“Unicycive Therapeutics, Inc. (Nasdaq: UNCY), today announced the successful completion of the UNI-494 Phase 1 study in healthy volunteers.” not found on the page
Checked 7 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- UNI-494 Phase 1 study results
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesGemini (Google) re-read the evidence blind and read it as “Late”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Unicycive Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2024-UNCY-002805 · Corrections policy